Low-density lipoprotein and other predictors of response with telaprevir-based therapy in treatment-experienced HCV genotype 1 patients: REALIZE study
Volume
35
Pagination
448 - 454
DOI
10.1111/liv.12703
Journal
LIVER INTERNATIONAL
Issue
ISSN
1478-3223
Metadata
Show full item recordAuthors
Berg, T; Andreone, P; Pol, S; Roberts, S; Younossi, Z; Diago, M; Lawitz, EJ; Focaccia, R; Foster, GR; Horban, ACollections
- Centre for Immunobiology [1260]